Company
Biotronik
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
32
510(k), De Novo and PMA
Device trials
132
As lead sponsor, any status
Adverse event reports
7,362
Received Nov 1, 2025 to Nov 20, 2026
Recall records
42
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Biotronik, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Biotronik.
Latest FDA decisions
The 8 newest of 32 since 2015.
- BIOMONITOR IV (471155)510(k)
K261074 · Decided May 1, 2026 · 30 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
K250706 · Decided Apr 4, 2025 · 25 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
- Pantera Pro; Pantera LEO510(k)
K242969 · Decided Oct 25, 2024 · 29 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
29 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT07118358 · 325 participants (planned) · Start Mar 16, 2026 · Primary completion Mar 2027
Device: LivIQ Leadless Pacemaker System · For: Leadless Pacemaker; Bradycardia; AV Block and 1 more
Sites: Burlingame, California; La Jolla, California; Laguna Hills, California · 45 sites in all
- A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote ManagementActive, not recruiting
NCT04683718 · 60 participants (planned) · Start Sep 20, 2021 · Primary completion Aug 21, 2025
Device: Permanent implant of a BIOTRONIK Prospera SCS (Spinal Cord Stimulation) System with HomeStream Remote Management · For: Chronic Low-back Pain; Chronic Leg Pain
Sites: Broadmeadow, Australia; Hurstville, Australia; Wahroonga, Australia · 5 sites in all
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo LesionsActive, not recruiting
NCT07091682 · 100 participants (planned) · Start Feb 18, 2025 · Primary completion Jun 2027
Device: Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold · For: Coronary Artery Disease; Atherosclerosis of Coronary Artery; Myocardial Ischemia and 3 more
Sites: Erfurt, Germany; Halle, Germany; Immenstadt and Kempten, Germany · 14 sites in all
129 more trials with a free account
Reports received
7,362
Received Nov 1, 2025 to Nov 20, 2026. Includes 4 of another or unstated type.
Malfunction reports
2,292
31% of reports
Injury reports
5,041
68% of reports
Death reports
25
0.3% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 344 | 141 | 6 | 0 |
| Jan 24 | 452 | 202 | 1 | 0 |
| Feb 24 | 401 | 184 | 4 | 0 |
| Mar 24 | 488 | 190 | 2 | 0 |
| Apr 24 | 406 | 251 | 3 | 0 |
| May 24 | 396 | 186 | 2 | 0 |
| Jun 24 | 406 | 190 | 2 | 0 |
| Jul 24 | 409 | 158 | 0 | 0 |
| Aug 24 | 417 | 203 | 1 | 0 |
| Sep 24 | 340 | 169 | 3 | 0 |
| Oct 24 | 445 | 197 | 1 | 0 |
| Nov 24 | 325 | 152 | 1 | 0 |
| Dec 24 | 345 | 171 | 1 | 0 |
| Jan 25 | 469 | 269 | 0 | 0 |
| Feb 25 | 398 | 153 | 2 | 1 |
| Mar 25 | 379 | 159 | 3 | 0 |
| Apr 25 | 395 | 191 | 2 | 0 |
| May 25 | 362 | 195 | 2 | 0 |
| Jun 25 | 349 | 155 | 1 | 1 |
| Jul 25 | 381 | 201 | 3 | 0 |
| Aug 25 | 424 | 242 | 1 | 1 |
| Sep 25 | 373 | 195 | 3 | 1 |
| Oct 25 | 378 | 217 | 4 | 0 |
| Nov 25 | 377 | 205 | 2 | 0 |
| Dec 25 | 408 | 238 | 0 | 0 |
| Jan 26 | 233 | 412 | 2 | 0 |
| Feb 26 | 147 | 466 | 5 | 0 |
| Mar 26 | 175 | 533 | 3 | 0 |
| Apr 26 | 176 | 457 | 2 | 1 |
| May 26 | 119 | 465 | 0 | 0 |
| Jun 26 | 155 | 484 | 2 | 0 |
| Jul 26 | 120 | 325 | 0 | 0 |
| Aug 26 | 129 | 483 | 6 | 3 |
| Sep 26 | 124 | 499 | 1 | 0 |
| Oct 26 | 129 | 474 | 2 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- SOLIA S 53650
- SOLIA S 60479
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1441-2021 · Started Mar 8, 2021
Reason given: There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
Cause as FDA categorized it: Device Design · Device type: Defibrillator, Implantable, Dual-Chamber (MRM)
Z-1442-2021 · Started Mar 8, 2021
Reason given: There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
Cause as FDA categorized it: Device Design · Device type: Defibrillator, Implantable, Dual-Chamber (MRM)
Z-1443-2021 · Started Mar 8, 2021
Reason given: There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
Cause as FDA categorized it: Device Design · Device type: Defibrillator, Implantable, Dual-Chamber (MRM)
39 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.